Defense Advanced Research Projects AgencyTagged Content List

Restore and Maintain Warfighter Abilities

Relating to the restoration and optimization of human health

Showing 4 results for Health + Chemistry RSS
06/21/2016
Soldiers often operate in extreme environments, where they may be exposed to the elements for long periods of time. Standard equipment such as electronics and armor are designed to withstand such stresses, but that is not true for the contents of a medic’s bag. Most medicines, including essential biotherapeutics such as insulin, degrade rapidly when stored outside of specified temperature, humidity, and light conditions. DARPA’s Fold F(x) program aims to develop new classes of rugged, shelf-stable medicines based on non-natural, synthetic polymers that can better withstand extreme conditions in the field. The Agency will hold a workshop next week to describe recent successes and discuss applications with potential collaborators.
03/01/2018
When a Service member suffers a traumatic injury or acute infection, the time from event to first medical treatment is usually the single most significant factor in determining the outcome between saving a life or not. First responders must act as quickly as possible, first to ensure a patient’s sheer survival and then to prevent permanent disability. The Department of Defense refers to this critical, initial window of time as the “golden hour,” but in many cases the opportunity to successfully intervene may extend much less than sixty minutes, which is why the military invests so heavily in moving casualties as rapidly as possible from the battlefield to suitable medical facilities.
March 20, 2018,
Webinar
DARPA’s Biological Technologies Office is hosting an online-only Proposers Day webinar to provide information to potential applicants on the structure and objectives of the new Biostasis program. Biostasis aims to extend the time for lifesaving medical treatment following traumatic injury or acute infection by developing novel, non-thermal, molecular interventions to reversibly slow and/or pause the functions of living cells and preserve their viability.
Health threats often evolve more quickly than health solutions. Despite ongoing research in the government and the biopharmaceutical industry to identify new therapies, the Department of Defense (DoD) currently lacks tools to address the full spectrum of chemical, biological, and disease threats that could impact the readiness of U.S. forces.